Tislelizumab,Sorafenib
BeiGene,bayer
['tislelizumab', '$bgne', 'beigene']
#beigene announces data presentations at #esmo22 including late-breaking oral presentation for #tislelizumab in first-line #unresectable #hepatocellularcancer $bgne 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.